Modern Obesity Treatments are changing the weight-loss landscape. Over the last few years, GLP-1 and next-generation anti-obesity medicines have moved from specialist care into a global health mega trend – and this category is expected to grow significantly in the coming years.

At Azento Health, we are building a portfolio of microbiome-based companion solutions to support people before, during, and after anti-obesity medication treatment – addressing key needs in gut health, digestive comfort, nutrition routines and long-term wellbeing.